• 제목/요약/키워드: colonic uptake

검색결과 12건 처리시간 0.035초

네거티브 경구 조영제를 이용한 PET/CT 촬영시 나타난 종양성 섭취와 유사한 생리적 장관 섭취 (Colon Cancer Mimicking Physiologic FDG Uptake : with Using of Negative Oral Contrast)

  • 정영진;강도영
    • Nuclear Medicine and Molecular Imaging
    • /
    • 제40권3호
    • /
    • pp.186-187
    • /
    • 2006
  • A 64-year-old female with glioblastoma multiforme (GBM) was assigned to our department for whole body PET/CT scan. She ingested 1 liter of pure water as negative oral contrast just before PET/CT examination. FDG-PET/CT images showed a very intense hypermetabolic, focal lesion in the abdominal cavity around descending colon. The SUVmax of the lesion was 17.2. But there was no abnormal lesion corresponded to the area of PET scan in the combined contrast enhanced CT scan. We suggested considering a malignant lesion due to very intense glycolytic activity. Conventional abdominal CT scan & colonoscopy were accomplished within one week after PET/CT evaluation. There was no abnormality in both examinations. We executed follow-up PET/CT evaluation after 1 month and couldn't find any abnormality around the corresponding area. So we concluded the hypermetabolism was colonic physiologic uptake. A colonic physiologic uptake is a well known cause of false positive finding. Nuclear physicians should be considered the possibility of malignancy when interpret focal colonic uptake, especially incidental finding. There are a few reports that using of negative oral contrast is able to reduce gastrointestinal physiologic uptakes. But as we can see in this case, although we used negative oral contrast, intense physiologic uptake is detected and maxSUV is able to up to 17.2. So, it is important to keep a fact in mind. Even though there is a colonic physiologic uptake in PET/CT image, it may be able to show very intense hypermetabolism regardless of using negative oral contrast.

장관 내 국소 섭취증가 병소의 감별에 있어 추가 지연 F-18 FDG PET/CT의 임상적 유용성 (The Clinical Value of Dual Time Point F-18 FDG PET/CT Imaging for the Differentiation of Colonic Focal Uptake Lesions)

  • 김진숙;임석태;정영진;김동욱;정환정;손명희
    • Nuclear Medicine and Molecular Imaging
    • /
    • 제43권4호
    • /
    • pp.309-316
    • /
    • 2009
  • 목적: $^{18}$F-FDG PET/CT는 다양한 장관내 악성 종양을 발견하는데 높은 민감도를 보이고 있다. 하지만 $^{18}$F-FDG가 다양한 형태로 장관 내 생리적, 병리적 섭취증가를 보이기 때문에 그 특이도는 낮다. 이 연구는 장관 내 국소적인 $^{18}$F-FDG 섭취증가를 보일 때 생리적 섭취와 병리적 섭취를 감별하는 데 있어 추가 지연(dual time point) $^{18}$F-FDG PET/CT의 임상적 유용성을 알아보고자 하였다. 대상 및 방법: 2007년 1월부터 2008년 6월까지 장관 내 국소적인 섭취증가를 보여 추가 지연 촬영 $^{18}$F-FDG PET/CT를 실시한 132명(남:여=77:55, 나이 62.8$\pm$11.6세)을 대상으로 하였다. $^{18}$F-FDG 정맥 주사 후 50-60분 후에 조기 영상을 촬영하였고, 정맥 주사 후 4-5시간에 국소 섭취 증가 부위를 포함하고 있는 복부 부위에 대해 추가 지연 촬영을 실시하였다. 초기 영상에서 보였던 국소적 섭취가 지연 영상에서 보이지 않거나 이동하였을 경우에는 생리적 섭취증가로 간주하였고, 지연 영상에서 지속적으로 관찰되는 섭취증가에 대해서는 대장내시경과 병리조직 검사를 실시하였다. 지연 영상에서 지속적으로 관찰되는 장관 내 섭취에 대해서는 각각 Suvmax값과 조기 영상과 지연 영상의 Syvmax값의 차이($\Delta$%Suvmax)를 계산하였다. 결과: 132명의 환자에서 153개의 국소적 섭취증가병소를 관찰할 수 있었다. 이 중 72개 병소에서는 지연 영상에서 섭취 증가가 사라져 생리적 섭취로 판단할 수 있었다. 조기 영상에서만 보였던 생리적 섭취는 맹장을 포함한 오름 결장에서 가장 많이 관찰되었다. 지연 영상에서도 지속적으로 섭취증가를 보인 81개 병소에서 61개는 악성 종양으로 확진되었고, 14개는 양성 질환으로 확인 되었다. 나머지 6개의 병소는 대장내시경에서 특이소견을 보이지 않아 생리적 섭취로 확인되었다. 악성 종양은 $\Delta$%Suvmax가 20.8%$\pm$18.7%로 통계적으로 유의하게 증가하였고, 반대로 리 악성에서는 3.7%$\pm$24.2%로 감소하였다. 가장 유용한 진단적 가치를 주는 요소는 $\Delta$%Suvmax 임을 확인하였고, 악성과 비악성 질환을 감별하는데 임계수를 -5%로 정하였을 때 가장 좋은 민감도, 특이도, 정확도를 보였다. 결론: $^{18}$F-FDG PET/CT를 이용한 추가 지연 촬영은 생리적 섭취와 병리적 섭취를 감별하는데 있어 검사의 특이도를 높이고 불필요한 검사를 줄일 수 있는 유용한 비침습적 방법으로 생각된다.

Accuracy of FDG-PET/CT for Detection of Incidental Pre-Malignant and Malignant Colonic Lesions - Correlation with Colonoscopic and Histopathologic Findings

  • Kunawudhi, Anchisa;Wong, Alexandra K;Alkasab, Tarik K;Mahmood, Umar
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제17권8호
    • /
    • pp.4143-4147
    • /
    • 2016
  • Purpose: We evaluated all PET/CTs acquired for patients without a primary diagnosis of colorectal cancer, and compared results for those who had subsequent colonoscopy within 6 months, to assess the accuracy of FDG PET/CT for detection of incidental pre-malignant polyps and malignant colon cancers. Materials and Methods: Medical records of 9,545 patients who underwent F-18 FDG PET/CT studies over 3.5 years were retrospectively reviewed. Due to pre-existing diagnosis of colorectal cancer, 818 patients were excluded. Of the remainder, 157 patients had colonoscopy within 6 months (79 males; mean age 61). We divided the colon into 4 regions and compared PET/CT results for each region with colonoscopy and histopathologic findings. True positive lesions included colorectal cancer, villous adenoma, tubulovillous adenoma, tubular adenoma and serrated hyperplastic polyp/hyperplastic polyposis. Results: Of 157 patients, 44 had incidental colonic uptake on PET/CT (28%). Of those, 25 had true positive (TP) uptake, yielding a 48% positive predictive value (PPV); 9% (4/44) were adenocarcinoma. There were 23 false positive (FP) lesions of which 4 were hyperplastic polyp, one was juvenile polyp and 7 were explained by diverticulitis. Fifty eight patients had false negative PET scans but colonoscopy revealed true pre-malignant and malignant pathology, yielding 23% sensitivity. The specificity, negiative predictive value (NPV) and accuracy were 96%, 90% and 87%, respectively. The average SUVmax values of TP, FP and FN lesions were 7.25, 6.11 and 2.76, respectively. There were no significant difference between SUVmax of TP lesions and FP lesions (p>0.95) but significantly higher than in FN lesions (p<0.001). The average size (by histopathology and colonoscopy) of TP lesions was 18.1 mm, statistically different from that of FN lesions which was 5.9 mm (p<0.001). Fifty-one percent of FN lesions were smaller than 5 mm (29/57) and 88% smaller than 10 mm (50/57). Conclusions: The high positive predictive value of incidental focal colonic FDG uptake of 48% for colonic neoplasia suggests that colonoscopy follow-up is warranted with this finding. We observed a low sensitivity of standardly acquired FDG-PET/CT for detecting small polyps, especially those less than 5 mm. Clinician and radiologists should be aware of the high PPV of focal colonic uptake reflecting pre-malignant and malignant lesions, and the need for appropriate follow up.

Role of High-affinity Choline Transporter 1 in Colonic Hypermotility in a Rat Model of Irritable Bowel Syndrome

  • Lin, Meng-juan;Yu, Bao-ping
    • Journal of Neurogastroenterology and Motility
    • /
    • 제24권4호
    • /
    • pp.643-655
    • /
    • 2018
  • Background/Aims Irritable bowel syndrome (IBS) is a common disease characterized by intestinal dysmotility, the mechanism of which remains elusive. We aim to determine whether the high-affinity choline transporter 1 (CHT1), a determinant of cholinergic signaling capacity, modulates intestinal motility associated with stress-induced IBS. Methods A rat IBS model was established using chronic water avoidance stress (WAS). Colonic pathological alterations were evaluated histologically and intestinal motility was assessed by intestinal transit time and fecal water content (FWC). Visceral sensitivity was determined by visceromotor response to colorectal distension. RT-PCR, western blotting, and immunostaining were performed to identify colonic CHT1 expression. Contractility of colonic muscle strips was measured using isometric transducers. enzyme-linked immunosorbent assay was used to measure acetylcholine (ACh). We examined the effects of MKC-231, a choline uptake enhancer, on colonic motility. Results After 10 days of WAS, intestinal transit time was decreased and fecal water content increased. Visceromotor response magnitude in WAS rats in response to colorectal distension was significantly enhanced. Protein and mRNA CHT1 levels in the colon were markedly elevated after WAS. The density of CHT1-positive intramuscular interstitial cells of Cajal and myenteric plexus neurons in WAS rats was higher than in controls. Ammonium pyrrolidine dithiocarbamate partly reversed CHT1 upregulation and alleviated colonic hypermotility in WAS rats. Pharmacological enhancement of CHT1 activity by MKC-231 enhanced colonic motility in control rats via upregulation of CHT1 and elevation of ACh production. Conclusion Upregulation of CHT1 in intramuscular interstitial cells of Cajal and myenteric plexus neurons is implicated in chronic stress-induced colonic hypermotility by modulation of ACh synthesis via nuclear factor-kappa B signaling.

무증상 성인의 F-18-FDG PET 대장 섭취양상 : 대장내시경 소견과의 비교 (Colonic Uptake Patterns of F-18-FDG PET in Asymptomatic Adults: Comparison with Colonoscopic Findings)

  • 배문선;조유경;정성애;심기남;이홍수
    • 대한핵의학회지
    • /
    • 제39권1호
    • /
    • pp.15-20
    • /
    • 2005
  • 목적 : 건강검진 등을 목적으로 시행된 무증상의 성인에서 대장 섭취는 매우 자주 관찰되나 대장선종 및 암종에서 FDG 섭취가 보고되어 생리적인 FDG 섭취와 구별이 쉽지 않았다. 이에 저자들은 무증상 성인을 대상으로 FDG-PET을 시행하여 그 섭취 패턴과 섭취 강도를 조사하고 대장내시경 소견과 비교하였다. 대상 및 방법 : FDG-PET과 대장내시경을 모두 시행한 무증상인 64명($27{\sim}87$세, 남:여=31:33) 을 대상으로 하였다. FDG 섭취 양상은 focal, segmental, diffuse세 그룹으로 나누고 모든 환자에 대해 최대 SUV값을 구하고 병소의 크기 및 조직학 소견과 비교하였다. 결과 : Diffuse 53.1%, Segmental 26.5%, Focal 20.3%의 섭취양상을 보였으며, Diffuse 양상을 보이면 대부분에서 정상이었고 선종이 소수 발견되었으나 크기가 작았다. Focal 양상의 환자에서는 선종 또는 기타 병리 소견 등의 양성 대장내시경 결과를 더 많이 보였고 다른 두 섭취 양상에서보다. 발견된 선종의 크기가 컸다. 대장 섭취정도를 SUV로 측정하였을 때 내시경 음성인 환자들은 선종 및 기타 병리소견이 있는 내시경 양성환자보다 SUV가 낮았으나 선종의 크기에 따른 SUV의 차이는 없었다. 결론: 무증상 환자에서 FDG-PET를 시행하였을 때 본 연구에서 제시된 대장 섭취 패턴과 섭취강도에 따른 내시경 결과와의 관계가 대장 선종 및 기타 병소를 진단하거나 내시경 등의 다음 검사로의 진행 결정에 일부 역할을 할 것으로 기대된다.

Extensive Hepatic Uptake of Pz-peptide, a Hydrophilic Proline-Containing Pentapeptide, into Isolated Hepatocytes Compared with Colonocytes and Caco-2 Cells

  • Shin, Tae-Ha;Lee, Pung-Sok;Kwon, Oh-Seung;Chung, Youn-Bok
    • Archives of Pharmacal Research
    • /
    • 제26권1호
    • /
    • pp.70-75
    • /
    • 2003
  • The objective of the present study was to investigate the uptake process of 4-Phenylazobenzoxycarbonyl-Pro-Leu-Gly-Pro-D-Arg (Pz-peptide), a hydrophilic and collagenase-labile pentapeptide, by isolated hepatocytes. For comparison, the uptake of Pz-peptide by Caco-2 cells and colonic cells, two known paracellular routes of Pz-peptide, was also evaluated. A simple and sensitive reversed-phase HPLC assay method using UV detection has been developed. The coefficient of variation for all the criteria of validation were less than 15%. The method was, therefore, considered to be sutable for measuring the concentration of Pz-peptide in the biological cells. Pz-peptide was extensively uptaked into hepatocytes. The initial velocity of Pz-peptide uptake assessed from the initial slope of the curve was plotted as Eadie-Hofstee plots. The maximum velocity ($V_{max}$) and the Michaelis constant ($K_m$) were 0.190$\pm$0.020 $nmol/min/10^6$ cells and 12.1$\pm$3.23 $\mu$M, respectively. The permeability-surface area product ($PS{influx}$) was calculated to be 0.0157 ml/min/10^6$ cells. $V_{max}$ and $K_m$ values for Caco-2 cells were calculated to be 6.22$\pm$0.930 pmol/min/10^6$ cells and 82.8$\pm$8.37 $\mu$M, respectively, being comparable with those of colonocytes (6.04$\pm$1.03 pmol/min/10^6$ cells and 87.8$\pm$13.2 $\mu$M, respectively). $PS_{influx}$ values for Caco-2 cells and colonocytes were calculated to be 0.0751 $\mu$l/min/10^6$ cells and 0.0688 $\mu$l/min/10^6$ cells, respectively. The more pronounced uptake of Pz-peptide by hepatocytes, when compared with Caco-2 cells and colonocytes, is probably due to its specific transporter. In conclusion, Pz-peptide, a paracellularly transported pentapeptide in the intestine and ocular epithelia, was uptaked into hepatocytes extensively. Although Pz-peptide is able to be uptaked into the Caco-2 cells and colonocytes, it is less pronounced when compared with hepatocytes. $PS_{influx}$ values of Caco-2 cells and colonocytes for unbound Pz-peptide under linear conditions were less than 0.4% when compared with that of hepatocytes.

A Rare Case of Undifferentiated Carcinoma of the Colon Directly Invading the Duodenum

  • Jongryeul Lim;Jeongmin Choi;Hyun-Jung Kim;Soo In Choi
    • Journal of Digestive Cancer Research
    • /
    • 제11권1호
    • /
    • pp.49-54
    • /
    • 2023
  • Colorectal cancers often invade adjacent organs; however, direct duodenal invasion is rare. Adenocarcinoma is the most common type of colorectal cancer, but an undifferentiated carcinoma type is unusual. Herein, we present a case of undifferentiated carcinoma of the colon that directly invaded the duodenum and metastasized to distant lymph nodes. An 85-year-old female patient was admitted with a 7-cm-sized colonic mass invading the duodenum, detected by computed tomography. Positron emission tomography revealed fluorodeoxyglucose uptake in the colon, duodenum, and aortocaval lymph nodes. A large encircling mass in the ascending colon and an ulcerated mass in the duodenum were revealed by colonoscopy and esophagogastroduodenoscopy, respectively. Pathologic examinations of the colon and the duodenum revealed nonglandular, diffusely infiltrating atypical round cells, confirming undifferentiated carcinoma of the colon. The histologic type of this tumor was distinguished using immunohistochemical (IHC) markers. Finally, microscopic characteristics and IHC markers aided in identifying the histologic type of colorectal cancer.

Available phosphorus levels modulate gene expression related to intestinal calcium and phosphorus absorption and bone parameters differently in gilts and barrows

  • Julia Christiane Votterl;Jutamat Klinsoda;Simone Koger;Isabel Hennig-Pauka;Doris Verhovsek;Barbara U. Metzler-Zebeli
    • Animal Bioscience
    • /
    • 제36권5호
    • /
    • pp.740-752
    • /
    • 2023
  • Objective: Dietary phytase increases bioavailability of phytate-bound phosphorus (P) in pig nutrition affecting dietary calcium (Ca) to P ratio, intestinal uptake, and systemic utilization of both minerals, which may contribute to improper bone mineralization. We used phytase to assess long-term effects of two dietary available P (aP) levels using a one-phase feeding system on gene expression related to Ca and P homeostasis along the intestinal tract and in the kidney, short-chain fatty acids in stomach, cecum, and colon, serum, and bone parameters in growing gilts and barrows. Methods: Growing pigs (37.9±6.2 kg) had either free access to a diet without (Con; 75 gilts and 69 barrows) or with phytase (650 phytase units; n = 72/diet) for 56 days. Samples of blood, duodenal, jejunal, ileal, cecal, and colonic mucosa and digesta, kidney, and metacarpal bones were collected from 24 pigs (6 gilts and 6 barrows per diet). Results: Phytase decreased daily feed intake and average daily gain, whereas aP intake increased with phytase versus Con diet (p<0.05). Gilts had higher colonic expression of TRPV5, CDH1, CLDN4, ZO1, and OCLN and renal expression of TRPV5 and SLC34A3 compared to barrows (p<0.05). Phytase increased duodenal expression of TRPV5, TRPV6, CALB1, PMCA1b, CDH1, CLDN4, ZO1, and OCLN compared to Con diet (p<0.05). Furthermore, phytase increased expression of SCL34A2 in cecum and of FGF23 and CLDN4 in colon compared to Con diet (p<0.05). Alongside, phytase decreased gastric propionate, cecal valerate, and colonic caproate versus Con diet (p<0.05). Phytase reduced cortical wall thickness and index of metacarpal bones (p<0.05). Conclusion: Gene expression results suggested an intestinal adaptation to increased dietary aP amount by increasing duodenal trans- and paracellular Ca absorption to balance the systemically available Ca and P levels, whereas no adaption of relevant gene expression in kidney occurred. Greater average daily gain in barrows related to higher feed intake.

Colorectal Cancer Treatment and Survival: the Experience of Major Public Hospitals in South Australia over three Decades

  • Roder, David;Karapetis, Christos S;Wattchow, David;Moore, James;Singhal, Nimit;Joshi, Rohit;Keefe, Dorothy;Fusco, Kellie;Powell, Kate;Eckert, Marion;Price, Timothy J
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제16권6호
    • /
    • pp.2431-2440
    • /
    • 2015
  • Background: Registry data from four major public hospitals indicate trends in clinical care and survival from colorectal cancer over three decades, from 1980 to 2010. Materials and Methods: Kaplan-Meier productlimit estimates and Cox proportional hazards models were used to investigate disease-specific survival and multiple logistic regression analyses to explore first-round treatment trends. Results: Five-year survivals increased from 48% for 1980-1986 to 63% for 2005-2010 diagnoses. Survival increases applied to each ACPS stage (Australian Clinico-Pathological Stage), and particularly stage C (an increase from 38% to 68%). Risk of death from colorectal cancer halved (hazards ratio: 0.50 (0.45, 0.56)) over the study period after adjusting for age, sex, stage, differentiation, primary sub-site, health administrative region, and measures of socioeconomic status and geographic remoteness. Decreases in stage were not observed. Survivals did not vary by sex or place of residence, suggesting reasonable equity in service access and outcomes. Of staged cases, 91% were treated surgically with lower surgical rates for older ages and more advanced stage. Proportions of surgical cases having adjuvant therapy during primary courses of treatment increased for all stages and were highest for stage C (an increase from 5% in 1980-1986 to 63% for 2005-2010). Radiotherapy was more common for rectal than colonic cases. Proportions of rectal cases receiving radiotherapy increased, particularly for stage C where the increase was from 8% in 1980-1986 to 60% in 2005-2010. The percentage of stage C colorectal cases less than 70 years of age having systemic therapy as part of their first treatment round increased from 3% in 1980-1986 to 81% by 1995-2010. Based on survey data on uptake of adjuvant therapy among those offered this care, it is likely that all these younger patients were offered systemic treatment. Conclusions: We conclude that pronounced increases in survivals from colorectal cancer have occurred at major public hospitals in South Australia due to increases in stage-specific survivals. Use of adjuvant therapies has increased and the patterns of change accord with clinical guideline recommendations. Reasons for sub-optimal use of radiotherapy for rectal cases warrant further investigation, including the potential for limited rural access to impede uptake of treatments at metropolitan-based radiotherapy centres.